The Aptamers Market is gaining remarkable traction as these synthetic oligonucleotides increasingly demonstrate their potential as powerful tools in diagnostics, therapeutics, and targeted drug delivery systems. Aptamers, which are single-stranded DNA or RNA molecules capable of binding to specific targets such as proteins, peptides, or small molecules, are emerging as cost-effective...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt